DUBLIN--(BUSINESS WIRE)--The "Surgical Glue Market by Type, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com's offering.
The market growth is mainly driven by the rise in number of surgical procedures and burn cases along with increasing incidence of road accidents globally.
The cyanoacrylate is expected to be the highest growing category in the surgical glue market during the forecast period, due to its durability, strength, and waterproof nature. Increasing use of cyanoacrylate by end users in the adhesion and repair of tissues and blood vessels; plastic surgeries; topical or minor lacerations; surgical incisions; and ophthalmology is primarily driving its growth in the market.
Cardiac surgery application is expected to be the fastest-growing category in the surgical glue market, with a CAGR of 11.8% during the forecast period. This is attributed to global increase in cases of heart associated problems owing to prevalence of high blood pressure, high LDL cholesterol, and smoking habits among people.
Hospitals held the largest share during the historical period and is estimated to account for more than 80% of the surgical glue market in 2017. This can be attributed to the wide range of major surgeries performed in hospitals using surgical glue.
- The market will witness fastest growth in Asia-Pacific (APAC)
- Growing geriatric population is expected to drive the market growth
- Improving healthcare in different economies expected to provide growth opportunities to the market
- Advanced Medical Solutions Group PLC
- B. Braun Melsungen AG
- Baxter International Inc.
- C. R. Bard Inc.
- Cardinal Health Inc. Inc.
- Cohera Medical Inc.
- CryoLife Inc.
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Medtronic PLC
- Takeda Pharmaceutical Company Limited
For more information about this report visit https://www.researchandmarkets.com/research/zvcs3g/global_surgical?w=4